These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 6668496)

  • 1. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
    Abdel-Rahman O
    J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based staging system for cutaneous melanoma.
    Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
    CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
    Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.
    Amer MH; Al-Sarraf M; Vaitkevicius VK
    Surg Gynecol Obstet; 1979 Nov; 149(5):687-92. PubMed ID: 505243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
    Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
    Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival with regional and distant metastases from cutaneous malignant melanoma.
    Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
    Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous melanoma: prognosis and treatment results worldwide.
    Balch CM
    Semin Surg Oncol; 1992; 8(6):400-14. PubMed ID: 1439450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-IV melanoma and pulmonary metastases: factors predictive of survival.
    Neuman HB; Patel A; Hanlon C; Wolchok JD; Houghton AN; Coit DG
    Ann Surg Oncol; 2007 Oct; 14(10):2847-53. PubMed ID: 17680317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.